Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Xiangdong Lv(Baylor College of Medicine), Xi Chen(Baylor College of Medicine)
Cited by 103
Related Papers
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
|Journal of Clinical Investigation|2018|260
Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth
|Cancer Research|2021|46
Human cathelicidin antimicrobial peptide suppresses proliferation, migration and invasion of oral carcinoma HSC-3 cells via a novel mechanism involving caspase-3 mediated apoptosis
|Molecular Medicine Reports|2020|18
Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity
|Research Square|2024|1
Notch-Induced Endoplasmic Reticulum-Associated Degradation Governs Thymocyte β−Selection
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0